30
Oct

AstraZeneca won an FDA nod for a one-pill combination of its latest diabetes drug and the long-generic metformin, making it the second to market among a cadre of drugmakers developing similar cocktails.

…read more

Source: AstraZeneca wins another diabetes approval in a fast-crowding market

    

0 No comments